Edition:
United States

Chiasma Inc (CHMA.OQ)

CHMA.OQ on NASDAQ Stock Exchange Global Select Market

1.80USD
13 Dec 2017
Change (% chg)

$-0.05 (-2.70%)
Prev Close
$1.85
Open
$1.85
Day's High
$1.85
Day's Low
$1.80
Volume
2,443
Avg. Vol
14,774
52-wk High
$2.95
52-wk Low
$1.25

Select another date:

Thu, Nov 9 2017

BRIEF-Chiasma Q3 loss per share $0.28

* Chiasma Inc - ‍ cash, cash equivalents & marketable securities as of Sept 30, 2017 were $73.2 million, compared with $93.0 million as of December 31, 2016​ Source text for Eikon: Further company coverage:

BRIEF-Chiasma announces first patient is randomized in phase 3 trial of Octreotide capsules in patients with acromegaly

* Chiasma announces first patient is randomized in phase 3 chiasma optimal clinical trial of Octreotide capsules in patients with acromegaly

BRIEF-Chiasma reached deal with FDA on late-stage trial of its acromegaly drug

* Chiasma reaches agreement with FDA under special protocol assessment for a new phase 3 clinical trial of octreotide capsules in acromegaly

Select another date: